EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The Use of a Resorbable Membrane as an Adjunct to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: 3‐Year Results of a Randomised Clinical Trial

Carlotta Dionigi iD, Erik Regidor iD, Anna Trullenque-Eriksson iD, Jan Derks iD, Mariano Sanz iD, Alberto Ortiz-Vigón

Journal of Clinical Periodontology · 2026-02 · 53 (2) · 268-285

DOI: 10.1111/jcpe.70057 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 03.11.2025. Verfasst von Carlotta Dionigi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Peri-Implantitis, Membranes, Artificial, Bone Substitutes, Absorbable Implants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Geistlich Pharma, Arrow Development SL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the effect of the adjunctive use of a resorbable collagen membrane in the reconstructive surgical therapy of peri‐implantitis. Material and Methods Forty‐three patients (43 implants) diagnosed with peri‐implantitis underwent surgical treatment using a reconstructive approach, which included a bone substitute material with (test) or without (control) a resorbable collagen membrane. Supportive peri‐implant treatment was administered biannually during the 3‐year follow‐up period. Clinical outcomes, such as probing pocket depth (PPD), bleeding on probing (BOP), suppuration on probing (SOP), marginal mucosal level (REC) and keratinised mucosa width (KM), were recorded at baseline, as well as at 6, 12 and 36 months. Radiographic marginal bone levels (MBLs) and patient‐reported outcomes (PROs) were also evaluated. The primary outcome was a composite measure consisting of PPD ≤ 5 mm, absence of BOP/SOP and buccal REC of ≤ 1 mm. A second composite outcome, termed ‘disease resolution’, was also assessed, defined as PPD ≤ 5 mm, BOP at ≤ 1 site and complete absence of SOP.

Results

Out of the 43 participants, 8 were lost to follow‐up, 2 experienced implant loss and 1 was surgically re‐treated. At 3 years, the composite outcome was achieved for 25.0% of implants (test: 17.6%; control: 27.8%), while disease resolution was achieved for 31.2% (test: 29.4%; control: 27.8%). Overall, PPD and BOP were reduced by 3.6 ± 3.2 mm and 37.5% ± 42.1%, respectively. Changes in buccal REC and KM were 0.5 ± 1.3 and 1.1 ± 1.5 mm, respectively. An overall bone gain (MBL change) of 1.0 ± 2.2 mm was observed. PROs were favourable. No statistically significant differences were observed between groups.

Conclusion

Adding a collagen membrane to a bone substitute material in the surgical treatment of peri‐implantitis did not yield any benefits regarding clinical, radiographic or patient‐reported outcomes. Trial Registration: ISRCTN67095066 ( https://www.isrctn.com/ISRCTN67095066 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peri-ImplantitisMembranes, ArtificialBone SubstitutesAbsorbable ImplantsBone TransplantationHumansMaleFemaleMiddle AgedCollagenTreatment OutcomeAgedAdultAlveolar Bone LossPeriodontal IndexFollow-Up StudiesHeterografts

Stichwörter der Autor:innen

barrier membranebone regenerationclinical trialperi‐implant defectperi‐implantitisreconstructive therapy

Substanzen

Membranes, ArtificialBone SubstitutesCollagen

Autor:innen und Institutionen

  • Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Thinking Perio Research, Clínica Ortiz-Vigón PerioCentrum Bilbao, Spain.
  • Faculty of Odontology, University Complutense of Madrid, Madrid, Spain.

ORCID-Profile: Carlotta Dionigi, Erik Regidor, Anna Trullenque-Eriksson, Jan Derks, Mariano Sanz

Förderung

  • Geistlich Pharma
  • Arrow Development SL

Zitieren

APA

Dionigi, C., Regidor, E., Trullenque-Eriksson, A., Derks, J., Sanz, M., & Ortiz-Vigón, A. (2026). The Use of a Resorbable Membrane as an Adjunct to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: 3‐Year Results of a Randomised Clinical Trial. Journal of Clinical Periodontology, 53(2), 268-285. https://doi.org/10.1111/jcpe.70057

Vancouver

Dionigi C, Regidor E, Trullenque-Eriksson A, Derks J, Sanz M, Ortiz-Vigón A. The Use of a Resorbable Membrane as an Adjunct to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: 3‐Year Results of a Randomised Clinical Trial. Journal of Clinical Periodontology. 2026;53(2):268-285. doi:10.1111/jcpe.70057

BibTeX
@article{Dionigi2026,
  author = {Dionigi, Carlotta and Regidor, Erik and Trullenque-Eriksson, Anna and Derks, Jan and Sanz, Mariano and Ortiz-Vigón, Alberto},
  title = {The Use of a Resorbable Membrane as an Adjunct to a Xenogeneic Bone Replacement Graft in the Reconstructive Surgical Therapy of Peri‐Implantitis: 3‐Year Results of a Randomised Clinical Trial},
  journal = {Journal of Clinical Periodontology},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {268--285},
  doi = {10.1111/jcpe.70057}
}
Kostenlos starten →